Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Pablo E. Vivas-Mejia"'
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 26-26 (2024)
OBJECTIVES/GOALS: This project focuses on investigating the potential of Simalikalactone D (SKD) as an anticancer agent, exploring the mechanisms underlying SKD’s induction of cell death, and assessing the impact of SKD on diverse breast cancer cel
Externí odkaz:
https://doaj.org/article/4f76c2223a14459c84c9f4538c391489
Autor:
Nilmary Grafals-Ruiz, Annelis O. Sánchez-Álvarez, Yasmarie Santana-Rivera, Eunice L. Lozada-Delgado, Robert J. Rabelo-Fernandez, Christian I. Rios-Vicil, Fatima Valiyeva, Pablo E. Vivas-Mejia
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionGlioblastoma (GBM) is a highly aggressive and lethal primary brain tumor. Despite limited treatment options, the overall survival of GBM patients has shown minimal improvement over the past two decades. Factors such as delayed cancer diag
Externí odkaz:
https://doaj.org/article/729159b29ebf449a8320808f42799637
Autor:
Betzaida Castillo Cruz, Marienid Flores Colón, Robert J. Rabelo Fernandez, Pablo E. Vivas-Mejia, Gabriel L. Barletta
Publikováno v:
ACS Omega, Vol 7, Iss 4, Pp 3731-3737 (2022)
Externí odkaz:
https://doaj.org/article/57cdd35469424d47a23ed4ae224ef9dc
Autor:
Robert J. Rabelo-Fernández, Ricardo A. Noriega Rivera, Yasmarie Santana Rivera, José Tous-Beveraggi, Fatima Valiyeva, Pablo E. Vivas-Mejia
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 14742 (2022)
RNA-Binding Protein with Multiple Splicing (RBPMS) is a member of family proteins that bind to nascent RNA transcripts and regulate their splicing, localization, and stability. Evidence indicates that RBPMS controls the activity of transcription fact
Externí odkaz:
https://doaj.org/article/25e65311306644bf9d5b6ca09a1bfba7
Publikováno v:
Frontiers in Medical Technology, Vol 3 (2021)
Glioblastoma (GBM) is the most malignant form of all primary brain tumors, and it is responsible for around 200,000 deaths each year worldwide. The standard therapy for GBM treatment includes surgical resection followed by temozolomide-based chemothe
Externí odkaz:
https://doaj.org/article/236f1978127849348c04f955b425cf57
Autor:
Robert J. Rabelo-Fernández, Ginette S. Santiago-Sánchez, Rohit K. Sharma, Abiel Roche-Lima, Kelvin Carrasquillo Carrion, Ricardo A. Noriega Rivera, Blanca I. Quiñones-Díaz, Swetha Rajasekaran, Jalal Siddiqui, Wayne Miles, Yasmarie Santana Rivera, Fatima Valiyeva, Pablo E. Vivas-Mejia
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 1, p 535 (2022)
Worldwide, the number of cancer-related deaths continues to increase due to the ability of cancer cells to become chemotherapy-resistant and metastasize. For women with ovarian cancer, a staggering 70% will become resistant to the front-line therapy,
Externí odkaz:
https://doaj.org/article/2c3f44bbc9fd41e5ac467917478e72c2
Publikováno v:
Journal of Clinical and Translational Science, Vol 3, Pp 112-112 (2019)
OBJECTIVES/SPECIFIC AIMS: High-grade serous ovarian carcinoma (HGSOC) is the most common and malignant histological subtype of epithelial ovarian cancer. While the majority of HGSOC patients initially respond to platinum-based chemotherapy, they ofte
Externí odkaz:
https://doaj.org/article/bbed62248c0e4c2d82aa899110902ad6
Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes
Publikováno v:
Pharmaceuticals, Vol 6, Iss 11, Pp 1361-1380 (2013)
Nanomedicine is a growing research field dealing with the creation and manipulation of materials at a nanometer scale for the better treatment, diagnosis and imaging of diseases. In cancer medicine, the use of nanoparticles as drug delivery systems h
Externí odkaz:
https://doaj.org/article/7c25cf8642b1422cbf9df2d4a9e4dc3b
Autor:
Anil K. Sood, Robert L. Coleman, Pablo E. Vivas-Mejia, Ju-Seog Lee, Prahlad Ram, Vasudha Sehgal, Heather J. Dalton, Nicholas B. Jennings, Alpa M. Nick, Behrouz Zand, Lingegowda S. Mangala, Cristina Ivan, Wei Hu, Rebecca A. Previs, Whitney S. Graybill, Yunfei Wen
Supplementary Video 2. 3-D SKOV3ip1 spheroids expressing pGFP-RFP-LC3 were treated with MORAB-003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6428c811eecf4e914c72dfdaa4195e20
https://doi.org/10.1158/1078-0432.22460324.v1
https://doi.org/10.1158/1078-0432.22460324.v1
Autor:
Anil K. Sood, Parkash S. Gill, Gabriel Lopez-Berestein, Valery Krasnoperov, Yue Zhou, Pablo E. Vivas-Mejia, Robert L. Coleman, William M. Merritt, Yvonne G. Lin, Nicholas B. Jennings, Ren Liu, Alpa M. Nick, Myrthala Moreno-Smith, Sun-Joo Lee, Mian M.K. Shahzad, Masato Nishimura, Amy R. Carroll, Rebecca L. Stone, Lingegowda S. Mangala, Whitney A. Spannuth
EphB4 is a transmembrane receptor tyrosine kinase that plays an important role in neural plasticity and angiogenesis. EphB4 is overexpressed in ovarian cancer and is predictive of poor clinical outcome. However, the biological significance of EphB4 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8501cbac8362877b0e4244ba73e2362c
https://doi.org/10.1158/1535-7163.c.6531744
https://doi.org/10.1158/1535-7163.c.6531744